 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Nykode Therapeutics ASA is a clinical-stage biopharmaceutical company which engages in discovering and developing of novel immunotherapies. It focuses on developing field of individualized cancer neoantigen vaccines by using the Vaccibody technology to generate therapeutics to treat cancer. The company was founded by Inger Sandlie and Agnete Brunsvik Fredriksen on November 22, 2006 and is headquartered in Oslo, Norway.

Watchers
52-Wk Low	$2.29
52-Wk High	$2.36

Market Cap	$697.37M
Volume (M)	1.00
52-Wk High	$2.36
52-Wk Low	$2.29

Current Price	$2.36
Prev Close	$2.29
Open	$2.36
Dividend Yield	0.00%
50-Day Moving Average	$2.36
Beta	0.00
Avg. Volume	0.04
PE Ratio	-14.84

52-Week High	$2.36
52-Week Low	$2.29
Market Capitalization	$697.37M
EPS	-$0.159
Price to Book	4.99
Revenue Per Employee	$73,961.29
Enterprise Value/EBITDA	-9.25

VACBF Nykode Therapeutics AS

About

Feed

News

Earnings

Fundamentals